Article ; Online: Tissue-adjusted pathway analysis of cancer (TPAC): A novel approach for quantifying tumor-specific gene set dysregulation relative to normal tissue.
2024 Volume 20, Issue 1, Page(s) e1011717
Abstract: We describe a novel single sample gene set testing method for cancer transcriptomics data named tissue-adjusted pathway analysis of cancer (TPAC). The TPAC method leverages information about the normal tissue-specificity of human genes to compute a ... ...
Abstract | We describe a novel single sample gene set testing method for cancer transcriptomics data named tissue-adjusted pathway analysis of cancer (TPAC). The TPAC method leverages information about the normal tissue-specificity of human genes to compute a robust multivariate distance score that quantifies gene set dysregulation in each profiled tumor. Because the null distribution of the TPAC scores has an accurate gamma approximation, both population and sample-level inference is supported. As we demonstrate through an analysis of gene expression data for 21 solid human cancers from The Cancer Genome Atlas (TCGA) and associated normal tissue expression data from the Human Protein Atlas (HPA), TPAC gene set scores are more strongly associated with patient prognosis than the scores generated by existing single sample gene set testing methods. |
---|---|
MeSH term(s) | Humans ; Neoplasms/genetics ; Gene Expression Profiling/methods |
Language | English |
Publishing date | 2024-01-11 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 2193340-6 |
ISSN | 1553-7358 ; 1553-734X |
ISSN (online) | 1553-7358 |
ISSN | 1553-734X |
DOI | 10.1371/journal.pcbi.1011717 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.